Biodesix, Inc., is a molecular diagnostics company that discovers and commercializes blood-based diagnostic tests to improve outcomes for patients with cancer. In its 10 year history, the company has experienced tremendous growth, which led to its inclusion in this year’s Inc. 500 list.
The annually published Inc. list ranks privately-held businesses in the United States by percentage revenue growth over a three-year period. Biodesix is the 22nd fastest-growing company in Inc.’s “Health” category, and is one of 14 Colorado-based businesses to make the top 500 this year.
From Memphis to Boulder, congrats and keep up the good work!